|
Index of reports
> Cases with Thrombocytopenia ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Isentress (Raltegravir) where reactions include thrombocytopenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Isentress side effects in male
Reported by a physician from France on 2012-08-16
Patient: male
Reactions: Agitation, Urinary Incontinence, Coma, Coma Scale Abnormal, Pyrexia, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, General Physical Health Deterioration, Encephalopathy, Faecal Incontinence, Convulsion, Respiratory Tract Congestion, Apathy, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Hyponatraemia, Cerebral Atrophy, White Blood Cell Disorder, Renal Failure, Hypoproteinaemia, Diarrhoea, Brain Abscess, Heart Rate Increased, Encephalitic Infection, Heart Sounds Abnormal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Acetaminophen
Dosage: df 10mg/ml
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Amikacin
Dosage: 900 mg daily
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Bactrim
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Cernevit-12
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Clarithromycin
Dosage: df 50mg/ml
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2012-05-01
Kaletra
Dosage: df 80/20 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Myambutol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Nefopam
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Olanzapine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
Perikabiven (Parenteral Nutrition)
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Potassium Chloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Prazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Rifabutin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Viramune
Indication: HIV Infection
Start date: 2012-03-01
End date: 2012-05-01
Other drugs received by patient: Propofol; Adavat
Possible Isentress side effects in male
Reported by a physician from France on 2012-08-15
Patient: male
Reactions: Agitation, Urinary Incontinence, Coma, Pyrexia, Coma Scale Abnormal, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, Encephalopathy, Faecal Incontinence, General Physical Health Deterioration, Convulsion, Apathy, Respiratory Tract Congestion, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Cerebral Atrophy, Hyponatraemia, Renal Failure, White Blood Cell Disorder, Diarrhoea, Hypoproteinaemia, Heart Rate Increased, Brain Abscess, Encephalitic Infection, Heart Sounds Abnormal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Acetaminophen
Dosage: df 10mg/ml
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Amikacin
Dosage: 900 mg daily
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Bactrim
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Cernevit-12
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Clarithromycin
Dosage: df 50mg/ml
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2012-05-01
Kaletra
Dosage: df 80/20 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Myambutol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Nefopam
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Olanzapine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
Perikabiven (Parenteral Nutrition)
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Potassium Chloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Prazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Rifabutin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Viramune
Indication: HIV Infection
Start date: 2012-03-01
End date: 2012-05-01
Other drugs received by patient: Adavat; Propofol
Possible Isentress side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13
Patient: male
Reactions: Confusional State, Agitation, Refusal of Treatment by Patient, Malnutrition, Anaemia, Coma, General Physical Health Deterioration, Pyrexia, Convulsion, Apathy, Hepatotoxicity, Diarrhoea, Thrombocytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Acetaminophen
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Acupan
Dosage: 120 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-16
End date: 2012-07-27
Amikacin
Dosage: 900 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Bactrim
Dosage: 800 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-13
Cernevit / 01027001 /
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-08-02
Clarithromycin
Dosage: 500 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Isentress
Dosage: unk
Administration route: Oral
Indication: HIV Infection
Start date: 2012-05-01
Kaletra
Dosage: unk
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Leucovorin Calcium
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Myambutol
Dosage: 2 df, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Olanzapine
Dosage: 1 df, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
Perikabiven
Dosage: unk
Indication: Parenteral Nutrition
Start date: 2012-07-10
Potassium Chloride
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Prazepam
Dosage: 1 df, qd
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Rifabutin
Dosage: 150 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Truvada
Dosage: unk
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Possible Isentress side effects in 17 year old female
Reported by a physician from United States on 2012-07-02
Patient: 17 year old female, weighing 74.4 kg (163.7 pounds)
Reactions: Agitation, Tachycardia, Coagulopathy, Blood Albumin Decreased, Treatment Noncompliance, Herpes Zoster, Rash Pruritic, Metapneumovirus Infection, Nystagmus, Oedema Peripheral, Deafness Unilateral, Menorrhagia, Feeling of Despair, Metabolic Acidosis, Rhinovirus Infection, Pain in Extremity, Family Stress, Anaemia, Encephalopathy, Toxicity To Various Agents, Cardiomyopathy, Tremor, Aggression, Hepatic Steatosis, Fungal Infection, Dehydration, Rash Erythematous, Aspartate Aminotransferase Increased, Pancreatitis, Haemolytic Anaemia, Diabetic Ketoacidosis, Mobility Decreased, Electrocardiogram QT Prolonged, Atelectasis, Otitis Media Chronic, Suicidal Ideation, Hypokalaemia, Speech Disorder, Myalgia, Fungaemia, Arthritis Reactive, Pleural Effusion, Tachypnoea, Opportunistic Infection, Depression, Apparent Life Threatening Event, Electrolyte Imbalance, Thrombocytopenia, Lethargy, Self-Injurious Ideation, Blood Glucose Increased, Renal Failure Acute, Pneumonia Bordetella, Fluid Overload, Type 2 Diabetes Mellitus, Alanine Aminotransferase Increased, Musculoskeletal Pain, Hyponatraemia, Ear Infection, Diarrhoea, Arthralgia, Sepsis, Progressive Multifocal Leukoencephalopathy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ceftazidime
Dosage: /q8h/iv
Indication: Pneumonia
End date: 2010-05-12
Enalapril Maleate
Dosage: /bid/po
Administration route: Oral
Indication: Cardiomyopathy
End date: 2010-05-12
Isentress
Dosage: 400 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2008-02-08
End date: 2009-01-14
Valtrex
Dosage: /bid/po
Administration route: Oral
Indication: Prophylaxis
End date: 2010-05-12
Vancomycin
Dosage: /q8h/iv
Indication: Pyrexia
End date: 2010-05-12
Other drugs received by patient: Pentamidine Isethionate
Possible Isentress side effects in 48 year old male
Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-06-28
Patient: 48 year old male
Reactions: Body Temperature Increased, Thrombocytopenia, Transaminases Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Intelence
Start date: 2012-03-07
End date: 2012-03-09
Isentress
Indication: HIV Infection
Start date: 2012-03-07
End date: 2012-03-09
Norvir
Start date: 2012-03-07
End date: 2012-03-09
Prezista
Indication: HIV Infection
Start date: 2012-03-07
End date: 2012-03-09
Possible Isentress side effects in 41 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04
Patient: 41 year old male
Reactions: Intussusception, Hepatic Function Abnormal, Coagulopathy, Anaemia, Toxicity To Various Agents, Death, Renal Failure, Thrombocytopenia, Pneumococcal Bacteraemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Isentress
Administration route: Oral
Indication: HIV Infection
Maraviroc
Indication: HIV Infection
Other drugs received by patient: Lamivudine; Etravirine; Enfuvirtide
Possible Isentress side effects in 41 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30
Patient: 41 year old male
Reactions: Intussusception, Hepatic Function Abnormal, Coagulopathy, Anaemia, Toxicity To Various Agents, Death, Renal Failure, Pneumococcal Bacteraemia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Isentress
Administration route: Oral
Indication: HIV Infection
Maraviroc
Indication: HIV Infection
Other drugs received by patient: Etravirine; Lamivudine; Enfuvirtide
Possible Isentress side effects in 45 year old male
Reported by a physician from United States on 2012-02-10
Patient: 45 year old male
Reactions: Renal Impairment, Anaemia, Thrombotic Thrombocytopenic Purpura, Thrombocytopenia, Sinusitis, Influenza Like Illness
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Isentress
Other drugs received by patient: Acyclovir; Atripla
Possible Isentress side effects in 45 year old male
Reported by a physician from United States on 2012-01-20
Patient: 45 year old male
Reactions: Renal Impairment, Anaemia, Thrombotic Thrombocytopenic Purpura, Thrombocytopenia, Sinusitis, Influenza Like Illness
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Isentress
Other drugs received by patient: Atripla; Acyclovir
Possible Isentress side effects in 17 year old female
Reported by a individual with unspecified qualification from United States on 2011-10-04
Patient: 17 year old female, weighing 69.9 kg (153.7 pounds)
Reactions: Agitation, Tachycardia, Deafness, Blood Albumin Decreased, Treatment Noncompliance, Herpes Zoster, Rash Pruritic, Face Oedema, Nystagmus, Metapneumovirus Infection, Cyanosis, Induration, Haemolytic Uraemic Syndrome, Respiratory Rate Increased, Metabolic Acidosis, Pneumonia, Rhinovirus Infection, Ear Disorder, Anaemia Haemolytic Autoimmune, Encephalopathy, Toxicity To Various Agents, Aggression, Hepatic Steatosis, Tremor, Dehydration, Ocular Hyperaemia, Rash Erythematous, Exfoliative Rash, Swelling, Pancreatitis, Diabetic Ketoacidosis, Rash Maculo-Papular, Atelectasis, Electrocardiogram QT Prolonged, Pain, Hypokalaemia, Suicidal Ideation, Myalgia, Fungaemia, Opportunistic Infection, Pleural Effusion, Tachypnoea, Toothache, Depression, Electrolyte Imbalance, Thrombocytopenia, Lethargy, Renal Failure Acute, Fluid Overload, Rash Generalised, Type 2 Diabetes Mellitus, Hyponatraemia, Ear Infection, Thrombotic Thrombocytopenic Purpura, Bronchiectasis, Diarrhoea, Arthralgia, Disease Recurrence, Alopecia, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Isentress
Other drugs received by patient: Pentamidine Isethionate
|
